Clinical Trial Update: Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study assessing safety, dosing, and pharmacokinetics of AVE8062 in combination with bevacizumab in adults with advanced malignant solid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasms

Drugs mentioned

• AVE8062
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms, Malignant | Phase 1 | Status: COMPLETED